DocMorris Ebit from 2010 to 2026
| DOCM Stock | 5.17 0.04 0.78% |
EBIT | First Reported 2009-12-31 | Previous Quarter -53.7 M | Current Value -53.6 M | Quarterly Volatility 26.9 M |
Check DocMorris financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DocMorris' main balance sheet or income statement drivers, such as Depreciation And Amortization of 55 M, Interest Expense of 24.1 M or Selling General Administrative of 31.1 M, as well as many indicators such as Price To Sales Ratio of 0.25, Dividend Yield of 0.0819 or PTB Ratio of 0.76. DocMorris financial statements analysis is a perfect complement when working with DocMorris Valuation or Volatility modules.
DocMorris | Ebit |
The evolution of Ebit for DocMorris AG provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how DocMorris compares to historical norms and industry peers.
Latest DocMorris' Ebit Growth Pattern
Below is the plot of the Ebit of DocMorris AG over the last few years. It is DocMorris' EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DocMorris' overall financial position and show how it may be relating to other accounts over time.
| Ebit | 10 Years Trend |
|
Ebit |
| Timeline |
DocMorris Ebit Regression Statistics
| Arithmetic Mean | (53,016,625) | |
| Geometric Mean | 29,676,155 | |
| Coefficient Of Variation | (116.26) | |
| Mean Deviation | 50,136,617 | |
| Median | (36,533,000) | |
| Standard Deviation | 61,638,270 | |
| Sample Variance | 3799.3T | |
| Range | 208M | |
| R-Value | (0.74) | |
| Mean Square Error | 1854.2T | |
| R-Squared | 0.54 | |
| Significance | 0.0007 | |
| Slope | (8,990,148) | |
| Total Sum of Squares | 60788.4T |
DocMorris Ebit History
About DocMorris Financial Statements
DocMorris investors use historical fundamental indicators, such as DocMorris' Ebit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in DocMorris. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| EBIT | -74.3 M | -78.1 M | |
| EBITDA | -33.3 M | -35 M | |
| Ebt Per Ebit | 1.13 | 0.81 | |
| Ebit Per Revenue | (0.12) | (0.11) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for DocMorris Stock Analysis
When running DocMorris' price analysis, check to measure DocMorris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DocMorris is operating at the current time. Most of DocMorris' value examination focuses on studying past and present price action to predict the probability of DocMorris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DocMorris' price. Additionally, you may evaluate how the addition of DocMorris to your portfolios can decrease your overall portfolio volatility.